Medical/Pharmaceuticals
Invivoscribe Partners with Complete Genomics to Develop and Commercialize Biomarker Tests for Oncology and Cancer Research
SAN DIEGO and SAN JOSE, Calif., June 2, 2023 /PRNewswire/ -- Invivoscribe and Complete Genomics announced today that they had entered a partnership to develop and commercialize biomarker tests on Complete Genomics' NGS platforms. The territory is worldwide, and the field is oncology and cancer...
2023-06-02 18:00
3207
Sunway Medical Centre Velocity Awarded by Frost & Sullivan for Leading the Malaysian Hospital Industry with Holistic Medical Care and Pioneering Technologies
Sunway Medical Centre Velocity in Kuala Lumpur delivers a wide range of medical specialties supported by highly trained professionals and advanced technologies. SAN ANTONIO, June 2, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the Malaysian hospital industry and, based on its finding...
2023-06-02 11:46
2721
Innovent Enters into Clinical Trial Collaboration with Merck KGaA, Darmstadt, Germany Investigating Combination Therapy of IBI351 (KRASG12C Inhibitor) and Cetuximab (ERBITUX®)for KRASG12C-mutated NSCLC in China
ROCKVILLE, Md. and SUZHOU, China, June 2, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
2023-06-02 08:00
5683
CAMH study confirms ongoing brain inflammation associated with long COVID
Researchers using advanced brain imaging are first to find increase in protein marker of inflammation in illness affecting 200 million globally TORONTO, June 2, 2023 /PRNewswire/ -- A new CAMH study published in the journalJAMA Psychiatry found elevated levels of inflammation in the brain of pa...
2023-06-02 04:07
2617
EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally
BEIJING, June 2, 2023 /PRNewswire/ -- EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today announced that it has established a strategic alliance with the China Resources Pharmaceutical Commercial Group, a leading pharmaceutical distribution ent...
2023-06-02 00:10
2813
Sirnaomics Dosed the First Patient in Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment
HONG KONG, Germantown, Md. and Suzhou, China, June 2, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company"; together with its subsidiaries, the "Group" or "Sirnaomics"; stock code: 2257), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today...
2023-06-02 00:06
6719
AtomVie Global Radiopharma raises over $90M to Complete its New Facility Buildout
HAMILTON, ON, June 1, 2023 /PRNewswire/ -- AtomVie Global Radiopharma Inc. (AtomVie), a global-leading CDMO for the GMP manufacturing and worldwide distribution of radiopharmaceuticals, today announced the closing of its Tranche 2 Series A financing led by its current investor, Avego Management, ...
2023-06-01 21:00
1790
YS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval From Philippines FDA
GAITHERSBURG, Md., June 1, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseas...
2023-06-01 20:30
2639
Croma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe
VIENNA, June 1, 2023 /PRNewswire/ -- Croma-Pharma, a global player and challenger in the dynamically growing, minimally invasive aesthetics market, announces that it will launch Pliaglis®, a topical local anaesthetic for superficial dermatological procedures, in its European core markets includin...
2023-06-01 17:18
3171
CRScube Expands Services in Europe with New Clinical Study Collaborations
SEOUL, South Korea, June 1, 2023 /PRNewswire/ -- CRScube, a leading provider of eClinical solutions, today announced its recent collaborations with two European companies. These new collaborations aim to expand the reach of CRScube's innovative eClinical solutions in the European clinical trial ...
2023-06-01 16:00
2235
New Genea Fertility Clinic to Open in North Melbourne
MELBOURNE, Australia , June 1, 2023 /PRNewswire/ -- Genea Fertility is pleased
to announce the expansion of its services inVictoria with the opening of a new
clinic inNorth Melbourne.
2023-06-01 15:58
2688
GenesisCare Files for Voluntary Reorganisation to Advance Business Transformation
Company to Obtain US$200 Million in New Financing to Support Ordinary Course Business Operations Globally All GenesisCare Businesses Show Strong Momentum and Growth Potential Company to Pursue Separation of U.S. Business While U.S. Management Implements Turnaround Strategy SYDNEY, June 1, 2023...
2023-06-01 14:09
2247
Antengene Announces XPOVIO® plus Bortezomib and Dexamethasone Included for Reimbursement by the PBS in Australia for the Treatment of Relapsed and/or Refractory Multiple Myeloma
- XPOVIO® (selinexor) is the first and only selective inhibitor of nuclear export (SINE) inhibitor approved by the Therapeutic Goods Administration (TGA) ofAustralia for patients with relapsed and/or refractory multiple myeloma (R/R MM) and in triple class refractory R/R MM. - This inclusion b...
2023-06-01 10:09
2979
National Comprehensive Cancer Network Joins Collaboration to Improve Standards in Cancer Care for Vietnam
United States-based NCCN representatives visit Hanoi, Vietnam to work with local experts to improve quality-of-life for patients with cancer throughout the country. PHILADELPHIA and HANOI, Vietnam, June 1, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—a not-for-profit a...
2023-06-01 09:00
2939
Mediso installs 100% cryogen-free 7T MRI at the University of Milano-Bicocca, Italy
BUDAPEST, Hungary, June 1, 2023 /PRNewswire/ -- Mediso
2023-06-01 09:00
2385
Brii Biosciences Announces First Subject Dosed in Phase 1 Clinical Trial of BRII-297, Long-Acting Injectable for the Treatment of Anxiety and Depressive Disorders
BRII-297, a first-of-its-kind treatment option for anxiety and depressive
disorders, has the potential to enable greater therapeutic adherence and
convenience for patients
DURHAM, N.C. and BEIJING, June 1, 2023 /PRNewswire/ -- Brii Biosciences
Limited
2023-06-01 08:00
2489
Argon Strengthens Biopsy Portfolio with SuperCore Advantage™ Instrument
PLANO, Texas, June 1, 2023 /PRNewswire/ -- Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology, announced the launch of the SuperCore Advantage™ Semi-Automatic Biopsy Instrument as the newest additio...
2023-06-01 00:57
2351
Advances of Qilu Pharmaceutical's QL1706 in Clinical Research Presented at ASCO Annual Meeting
JINAN, China, June 1, 2023 /PRNewswire/ -- The American Society of Clinical Oncology (ASCO) recently announced the selected abstracts for the prestigious ASCO 2023 Annual Meeting. Four clinical research abstracts on QL1706 (iparomlimab/tuvonralimab), an innovative bifunctional antibody for immun...
2023-06-01 00:55
2319
Vazyme Signs Global Strategic Cooperation Agreement with Azenta
NANJING, China, May 31, 2023 /PRNewswire/ -- Vazyme (688105.SH), China's leading biotechnology company, has officially signed a global strategic cooperation agreement with Azenta Life Sciences ("Azenta", Nasdaq: AZTA), which will promote to establish "one-stop" service process for both companies ...
2023-05-31 22:24
4445
Caliway Biopharmaceuticals Announces Initiation of Subject Recruitment in CBL-0204 Phase 2b Study Evaluating the Efficacy of CBL-514 in Abdominal Subcutaneous Fat Reduction
- Caliway has initiated the subject recruitment in CBL-0204 Phase 2b study. - The study is expected to be completed in Q2 2024, and the topline results are anticipated in Q3 2024. TAIPEI, May 31, 2023 /PRNewswire/ -- Caliway Biopharmaceuticals, a biopharmaceutical company focusing on breakthroug...
2023-05-31 20:15
2904
Week's Top Stories
Most Reposted
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 318 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 301 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
[Picked up by 272 media titles]
2024-05-10 15:20
Where does China's production capacity come from?
[Picked up by 258 media titles]
2024-05-10 12:01Most Read
Huawei Launching the All-Scenario Smart Telecom Power Solutions
2024-05-11 17:52
8601
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
2024-05-10 15:20
7969
Where does China's production capacity come from?
2024-05-10 12:01
7807
China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering
2024-05-10 21:20
4977